Literature DB >> 32633025

Uterine fibroids and preterm birth risk: A systematic review and meta-analysis.

Gonzalo R Pérez-Roncero1, María T López-Baena1, Lía Ornat1,2, Marcos J Cuerva3, Patricia Garcia-Casarrubios3, Peter Chedraui4,5, Faustino R Pérez-López1,2.   

Abstract

AIM: This study explored the association between the presence of uterine fibroids (UF), as determined by ultrasound, and preterm birth (PB) risk.
METHODS: Medline, Embase, Cochrane, Scopus and Web of Science databases. Studies reporting women with and without UF demonstrated by an ultrasound exam. The primary outcome was the risk of PB < 37 weeks of gestation in pregnancies with UF diagnosed by an obstetric ultrasound exam. Effects for dichotomous and continuous outcomes are, respectively, reported as risk ratios (RR) or mean differences and their 95% confidence intervals (CI).
RESULTS: Eighteen studies were included comprising 276 172 pregnancies to whom obstetric ultrasound assessment was performed for the presence/absence of UF. Women with UF were older (mean difference = 2.40 years, 95% CI 0.94-3.85) and were at higher risk of PB before 37 (RR = 1.43, 95% CI 1.27-1.60), 34 (RR = 1.79, 95% CI 1.32-2.42), 32 (RR = 1.94, 95% CI 1.33-2.85) and 28 (RR = 2.17, 95% CI 1.48-3.17) weeks as compared to those without UF (P < 0.01). In addition, women with UF were at higher risk of threatened preterm labor, preterm premature rupture of membranes, fetal malpresentation, placental abruption, lower gestational age and birthweight at delivery and a higher cesarean delivery rate.
CONCLUSION: Pregnant women with UF are at increased risk of PB and other adverse obstetric outcomes.
© 2020 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  birthweight; preterm birth; preterm delivery; ultrasound diagnosis; uterine fibroids; uterine myomas

Mesh:

Year:  2020        PMID: 32633025     DOI: 10.1111/jog.14343

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  5 in total

Review 1.  Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma.

Authors:  Anusha Shreenidhi Bhat; Ningthoujam Anirudh Singh; Emdormi Rymbai; Swapna Birendra; Saravanan Jayaram; Divakar Selvaraj
Journal:  Reprod Sci       Date:  2022-08-15       Impact factor: 2.924

2.  Natural history of fibroids in pregnancy: National Institute of Child Health and Human Development Fetal Growth Studies - Singletons cohort.

Authors:  Susanna D Mitro; Shyamal Peddada; Zhen Chen; Germaine M Buck Louis; Jessica L Gleason; Cuilin Zhang; Katherine L Grantz
Journal:  Fertil Steril       Date:  2022-08-16       Impact factor: 7.490

Review 3.  The Impact of Uterine Fibroids on Fertility: How the Uncertainty Widens the Gap in Reproductive Outcomes in Black Women.

Authors:  Chelsea A Henshaw; Mariam H Goreish; Megan E Gornet; Chantel I Cross
Journal:  Reprod Sci       Date:  2022-02-24       Impact factor: 2.924

4.  The risk of preterm birth in women with uterine fibroids: A systematic review and meta-analysis.

Authors:  Anadeijda J E M C Landman; Emma E Don; Guus Vissers; Hans C J Ket; Martijn A Oudijk; Christianne J M de Groot; Judith A F Huirne; Marjon A de Boer
Journal:  PLoS One       Date:  2022-06-02       Impact factor: 3.752

5.  Uterine Fibroids Causing Preterm Birth: A New Pathophysiological Hypothesis on the Role of Fibroid Necrosis and Inflammation.

Authors:  Emma E Don; Anadeijda J E M C Landman; Guus Vissers; Ekaterina S Jordanova; Emiel D Post Uiterweer; Christianne J M de Groot; Marjon A de Boer; Judith A F Huirne
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.